Tiziana Life Sciences PLC (LON:TILS – Get Free Report) shares passed above its 50 day moving average during trading on Friday . The stock has a 50 day moving average of GBX 58.50 ($0.74) and traded as high as GBX 59 ($0.74). Tiziana Life Sciences shares last traded at GBX 58.50 ($0.74), with a volume of 297,127 shares trading hands.
Tiziana Life Sciences Price Performance
The company has a 50 day moving average price of GBX 58.50 and a 200 day moving average price of GBX 58.50. The company has a current ratio of 6.54, a quick ratio of 6.41 and a debt-to-equity ratio of 2.36. The company has a market capitalization of £113.85 million and a price-to-earnings ratio of -3.59.
About Tiziana Life Sciences
Tiziana Life Sciences Plc, a clinical stage biotechnology company, focuses on the discovery and development of molecules and related diagnostics to treat diseases in oncology and immunology in the United Kingdom. Its product pipeline includes Foralumab (TZLS-401), a human anti-CD3 monclonal antibody for the treatment of autoimmune and inflammatory diseases, such as GvHD, ulcerative colitis, Crohn's disease, multiple sclerosis, type-1 diabetes, inflammatory bowel diseases, psoriasis, and rheumatoid arthritis; and Milciclib (TZLS-201), which is an orally bioavailable, small molecule inhibitor of cyclin-dependent kinases and Src family kinases for the treatment of hepatocellular carcinoma.
Further Reading
- Five stocks we like better than Tiziana Life Sciences
- 3 Tickers Leading a Meme Stock Revival
- Opal Fuels CEO on Steering the Future of Renewable Natural Gas
- How is Compound Interest Calculated?
- MicroStrategy Joins Nasdaq-100: 2 Crypto Stocks Set to Win
- 5 Top Rated Dividend Stocks to Consider
- 2 Underrated Quantum Computing Companies Starting to Rally
Receive News & Ratings for Tiziana Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tiziana Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.